☰

Christopher S. Kearn, Ph.D. - Publications

Affiliations: 
Medical College of Wisconsin, Milwaukee, WI, United States 
Area:
Neuropharmacology
Tree Info Grants Similar researchers PubMed Report error

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2008 Malone DT, Kearn CS, Chongue L, Mackie K, Taylor DA. Effect of social isolation on CB1 and D2 receptor and fatty acid amide hydrolase expression in rats. Neuroscience. 152: 265-72. PMID 18082330 DOI: 10.1016/j.neuroscience.2007.10.043  0.372
2008 Daigle TL, Kearn CS, Mackie K. Rapid CB1 cannabinoid receptor desensitization defines the time course of ERK1/2 MAP kinase signaling. Neuropharmacology. 54: 36-44. PMID 17681354 DOI: 10.1016/j.neuropharm.2007.06.005  0.543
2006 Pickel VM, Chan J, Kearn CS, Mackie K. Targeting dopamine D2 and cannabinoid-1 (CB1) receptors in rat nucleus accumbens. The Journal of Comparative Neurology. 495: 299-313. PMID 16440297 DOI: 10.1002/cne.20881  0.389
2005 Kearn CS, Blake-Palmer K, Daniel E, Mackie K, Glass M. Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors enhances heterodimer formation: a mechanism for receptor cross-talk? Molecular Pharmacology. 67: 1697-704. PMID 15710746 DOI: 10.1124/mol.104.006882  0.468
2004 Helliwell RJ, Chamley LW, Blake-Palmer K, Mitchell MD, Wu J, Kearn CS, Glass M. Characterization of the endocannabinoid system in early human pregnancy. The Journal of Clinical Endocrinology and Metabolism. 89: 5168-74. PMID 15472222 DOI: 10.1210/jc.2004-0388  0.33
2004 Carrier EJ, Kearn CS, Barkmeier AJ, Breese NM, Yang W, Nithipatikom K, Pfister SL, Campbell WB, Hillard CJ. Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a CB2 receptor-dependent mechanism. Molecular Pharmacology. 65: 999-1007. PMID 15044630 DOI: 10.1124/Mol.65.4.999  0.675
2004 Rademacher DJ, Kearn CS, Carrier EJ, Patel S, Delgado MA, Barkmeier A, Klick DE, Breese NM, Pfister SL, Nithipatikom K, Campbell WB, Hillard CJ. Production of hydroxyeicosatetraenoic acids and prostaglandins by a novel rat microglial cell line. Journal of Neuroimmunology. 149: 130-41. PMID 15020073 DOI: 10.1016/J.Jneuroim.2003.12.022  0.586
1999 Hillard CJ, Muthian S, Kearn CS. Effects of CB(1) cannabinoid receptor activation on cerebellar granule cell nitric oxide synthase activity. Febs Letters. 459: 277-81. PMID 10518035 DOI: 10.1016/S0014-5793(99)01253-3  0.536
1999 Kearn CS, Greenberg MJ, DiCamelli R, Kurzawa K, Hillard CJ. Relationships between ligand affinities for the cerebellar cannabinoid receptor CB1 and the induction of GDP/GTP exchange. Journal of Neurochemistry. 72: 2379-87. PMID 10349847 DOI: 10.1046/J.1471-4159.1999.0722379.X  0.645
1998 Edgemond WS, Hillard CJ, Falck JR, Kearn CS, Campbell WB. Human platelets and polymorphonuclear leukocytes synthesize oxygenated derivatives of arachidonylethanolamide (anandamide): their affinities for cannabinoid receptors and pathways of inactivation. Molecular Pharmacology. 54: 180-8. PMID 9658204 DOI: 10.1124/Mol.54.1.180  0.622
Show low-probability matches.